Actuarial AI: The Brain Behind Healthcare's Value Revolution

SAN FRANCISCO, CA – March 19, 2026 – More than 150 of the nation's top healthcare executives, payers, and providers gathered this week to confront a critical paradox: while the industry is committed to the promise of value-based care, many organizations still struggle to prove its financial viability. At the annual Arbital Health Summit, the conversation shifted from whether value-based models work to how to make them succeed financially, with a clear consensus emerging around the pivotal role of a new category of technology: Actuarial AI.

The invite-only event, focused on the future of risk contracting, underscored a persistent challenge in the healthcare sector. For years, the move away from fee-for-service to models that reward better patient outcomes has been a strategic goal. Yet, according to recent industry analyses, revenue tied to value-based contracts still hovers around 10% on average for many organizations. The core issue, echoed by leaders at the summit, is the difficulty in connecting clinical interventions to financial results within short, unforgiving contract cycles.

"What we heard from over 150 payer and provider leaders this year was that value-based care is working, but organizations often struggle to demonstrate financial impact," said Brian M. Overstreet, President and CEO of Arbital Health. He noted that leaders question how to bring "actuarial clarity to clinical interventions" and determine if AI investments are truly reducing costs. "That points to a clear need for a larger deployment of Actuarial AI infrastructure to support value-based risk contracting at scale."

The Evolutionary Revolution in Healthcare Economics

For decades, risk-based contracts have been hampered by operational complexity and fragmented data, making it difficult to proactively manage performance. Panelists at the summit noted a significant shift in how organizations are now approaching these problems, driven by artificial intelligence. The conversation is no longer about if AI will change healthcare, but how to harness it effectively.

"We're in the midst of what I would call an evolutionary revolution. AI is going to really transform the way we practice medicine and manage data," explained panelist Andrew C. Von Eschenbach, President of Samaritan Health Initiatives and a Former FDA Commissioner. "It enables us to make better decisions to care for patients. But it's a process that has to evolve... Once we acquire and aggregate all of this data and information, how do we properly analyze it so that we can confidently and comfortably react and act on it?"

This is where Actuarial AI is carving out its niche. By embedding actuarial logic directly into AI platforms, companies like Arbital Health are providing tools that offer a direct line-of-sight between patient outcomes and financial impact. For Accountable Care Organizations (ACOs), this technology is becoming essential for navigating complex patient journeys.

"The Arbital Summit gave me an opportunity to look beyond the day-to-day, and think about what technology and tools will give ACOs an even better, more complete understanding of the longitudinal patient journey," shared Emily Brower, President & CEO of the National Association of ACOs. "ACOs use data to deliver value to individual patients. We have enough evidence to illustrate what pathway works for a patient. You gain confidence to build that pathway and know that if I do A, there's a pretty good chance I will get B."

The Billion-Dollar Question: Is AI Inflationary or Deflationary?

A thought-provoking question, reportedly posed by former U.S. Chief Technology Officer Aneesh Chopra, hung over the summit's discussions: Is the widespread adoption of AI in healthcare ultimately inflationary or deflationary? The initial costs of implementation—software, hardware, and training—can be substantial, raising concerns about adding new layers of expense.

However, a growing body of economic analysis suggests the long-term impact will be powerfully deflationary. Experts project that AI integration could unlock annual savings between $200 billion and $360 billion in the U.S. healthcare system alone. These savings are expected to come from multiple fronts: automating administrative tasks, optimizing hospital operations, reducing costly medical errors, and enabling earlier disease detection through predictive analytics. By identifying at-risk patients sooner and personalizing treatment plans, AI helps prevent expensive emergency interventions and hospitalizations, driving down the total cost of care.

Mark Gwynne, Chief Value Officer at UNC Health, highlighted the importance of this debate at the event. "This was a group of executives that operate and think at a really high level, globally... Blending all those perspectives together is really interesting and different. There were several 'aha' moments around AI."

From Theory to Traction: Early Adopters Gain an Edge

The summit made it clear that the era of waiting for perfect conditions is over. The organizations demonstrating a measurable performance edge are those actively operationalizing advanced data analytics and AI-powered tools now. This momentum is validated by significant investor confidence in the sector.

Arbital Health, founded in 2023, has quickly amassed over $46 million in funding from prominent VBC-focused investors like Valtruis and Transformation Capital. In its first year, the company acquired Santa Barbara Actuaries to deepen its expertise and has already built a client roster of over 40 payers and providers, with its platform supporting over 600,000 patient lives. This market traction suggests a strong belief that its Actuarial AI platform, Merlin AI, provides a crucial competitive advantage.

Financial and clinical leaders at the summit described using such tools to surface hidden cost drivers and identify actions that have successfully "bent the cost curve." These results, playing out across hundreds of contract settlements, are beginning to fulfill the long-held promise of value-based care.

"Value-based care holds the promise of meeting healthcare's greatest challenge: delivering high-quality care at an affordable cost," synthesized Sam Deshpande, Former CIO of Humana. "I am excited to see Arbital Health's AI platform, along with leading voices across the industry, help shape the future."

As the industry accelerates its transition in 2026, the ability to make fast, data-informed decisions is no longer a luxury but a competitive necessity, with Actuarial AI emerging as the critical infrastructure powering that shift.